Paris, France and Eastleigh, UK – 13 July 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual General Meeting (AGM),...

RECOMMENDED CASH OFFER Novacyt UK Holdings Limited  (a wholly-owned subsidiary of Novacyt S.A.) for Yourgene Health plc  to be effected by means of a Scheme of Arrangement under Part 26...

AGM to be held in Paris on Thursday 10 August Paris, France and Eastleigh, UK – 15 June 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical...

Full year revenue and EBITDA in line with guidance Accelerating product development post-COVID-19 to become a leading global clinical diagnostic company in infectious diseases Paris, France and Eastleigh, UK 27 April 2023...

Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases Paris, France and Eastleigh, UK –...

Paris, France and Eastleigh, UK – 7 Dec 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that Edwin Snape has informed the Board...